Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s-Reference-Cited by-同舟云学术

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s

Published:2022-07-01 Issue:3 Volume:90 Page:343-350
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Brooks Kristina M.,Pinilla Mauricio,Stek Alice M.,Shapiro David E.,Barr Emily,Febo Irma L.,Paul Mary E.,Deville Jaime G.,George Kathleen,Knowles Kevin,Rungruengthanakit Kittipong,Browning Renee,Chakhtoura Nahida,Capparelli Edmund V.,Mirochnick Mark,Best Brookie M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference26 articles.

1. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel;Saag;JAMA,2020

2. Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide;Podany;AIDS,2018

3. Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir;Brooks;J Antimicrob Chemother.,2020

4. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults;Ruane;J Acquir Immune Defic Syndr.,2013

5. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials;Sax;Lancet,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women;Expert Opinion on Drug Metabolism & Toxicology;2024-05-14

2. Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection;Expert Review of Clinical Pharmacology;2023-09-07

3. Remdesivir Use in the Real-World Setting: An Overview of Available Evidence;Viruses;2023-05-14

4. Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy;Obstetrics and Gynecology Clinics of North America;2023-03